NCT06851351Completed
Respiratory Restriction in Prader-Willi Syndrome
Study of Respiratory Restriction in Patients With Prader-Willi Syndrome
Source: ClinicalTrials.gov · Last updated 28 Feb 2025
Brief summary (registry, in English)
The main aim of this study is therefore to evaluate the impact of Prader Willi Syndrome (PWS) on lung and thoracoabdominal volumes, respiratory muscle strength and awake ventilatory pattern, and to quantify and localize the PWS-induced respiratory restriction.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 24 Feb 2025
- Start date
- 16 Jan 2024
- Primary completion date
- 5 Jul 2024
- Lead sponsor
- Istituto Auxologico Italiano
- NCT number
- NCT06851351
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 16 Jan 2024 to the primary completion date, 5 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Lack of signed consent form
- Control subjects
- Lack of signed consent form
Who the study is looking for
- Age 20-50 years
- Prader Willi Syndrome
- Body Mass Index \> 30 kg/m2
- Age 20-50 years
- Body Mass Index \< 25 kg/m2
Criteria the registry did not label
- Patients with Prader Willi Syndrome
Age in the registry: 20 years to 50 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto Auxologico Italiano IRCCS, Site Piancavallo Coordinator of this site? Confirm its status | Oggebbio | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.